Dr Allen J Holmes, MD | |
265 Racine Dr Ste 102, Wilmington, NC 28403-8745 | |
(910) 399-6661 | |
Not Available |
Full Name | Dr Allen J Holmes |
---|---|
Gender | Male |
Speciality | Emergency Medicine |
Location | 265 Racine Dr Ste 102, Wilmington, North Carolina |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1952441842 | NPI | - | NPPES |
1952441842 | Other | NC | CHAMPUS |
5900923 | Medicaid | NC | |
7100040000 | Medicaid | KY | |
P00387855 | Other | WV | MEDICARE-RR PROVIDER NUMBER |
2795855 | Medicaid | OH | |
1952441842 | Medicaid | WV | |
P01165075 | Other | NC | RAILROAD MEDICARE |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207P00000X | Emergency Medicine | 22253 (West Virginia) | Secondary |
207P00000X | Emergency Medicine | 200500319 (North Carolina) | Primary |
Entity Name | Ecep Ii Pa |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1255407680 PECOS PAC ID: 5092709931 Enrollment ID: O20040413000773 |
News Archive
nSpire Health, LLC, a leading provider of respiratory diagnostic devices and clinical trial services, issued audited results for 2010 today. Sales of $27.6M are up 3% year over year. The Company reported a $3.6M improvement in EBIT when compared to 2009 and its highest profit since the founding of the company in 2006. Cash is up $2.4M and debt reduced to less than $400K.
The persistent overuse of antibiotics has led to the evolution of antibiotic resistant pathogens, or "superbugs," which can cause severe life-threatening infections that must be diagnosed and treated early on.
Ensuring that people with preexisting health conditions can get and keep health insurance is the most popular part of the Affordable Care Act. It has also become a flashpoint in this fall's campaigns across the country.
Particle Metrix, developers of versatile particle characterization solutions for the life sciences, report on the work of the Baur Laboratory in the Department of Dermatology at the University Hospital of Erlangen. The Group, which is part of the Translational Research Center at the University, is working to quantify extracellular vesicles in plasma of patients.
The U.S. Food and Drug Administration today approved TOBI Podhaler (tobramycin inhalation powder) for the management of cystic fibrosis patients with Pseudomonas aeruginosa, a bacterium that causes lung infections.
› Verified 8 days ago
Entity Name | Columbus Emergency Group Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1588813786 PECOS PAC ID: 2961560446 Enrollment ID: O20081028000380 |
News Archive
nSpire Health, LLC, a leading provider of respiratory diagnostic devices and clinical trial services, issued audited results for 2010 today. Sales of $27.6M are up 3% year over year. The Company reported a $3.6M improvement in EBIT when compared to 2009 and its highest profit since the founding of the company in 2006. Cash is up $2.4M and debt reduced to less than $400K.
The persistent overuse of antibiotics has led to the evolution of antibiotic resistant pathogens, or "superbugs," which can cause severe life-threatening infections that must be diagnosed and treated early on.
Ensuring that people with preexisting health conditions can get and keep health insurance is the most popular part of the Affordable Care Act. It has also become a flashpoint in this fall's campaigns across the country.
Particle Metrix, developers of versatile particle characterization solutions for the life sciences, report on the work of the Baur Laboratory in the Department of Dermatology at the University Hospital of Erlangen. The Group, which is part of the Translational Research Center at the University, is working to quantify extracellular vesicles in plasma of patients.
The U.S. Food and Drug Administration today approved TOBI Podhaler (tobramycin inhalation powder) for the management of cystic fibrosis patients with Pseudomonas aeruginosa, a bacterium that causes lung infections.
› Verified 8 days ago
Entity Name | J. Arthur Dosher Memorial Hospital |
---|---|
Entity Type | Part A Provider - Critical Access Hospital |
Entity Identifiers | NPI Number: 1538260229 PECOS PAC ID: 8921910324 Enrollment ID: O20091014000478 |
News Archive
nSpire Health, LLC, a leading provider of respiratory diagnostic devices and clinical trial services, issued audited results for 2010 today. Sales of $27.6M are up 3% year over year. The Company reported a $3.6M improvement in EBIT when compared to 2009 and its highest profit since the founding of the company in 2006. Cash is up $2.4M and debt reduced to less than $400K.
The persistent overuse of antibiotics has led to the evolution of antibiotic resistant pathogens, or "superbugs," which can cause severe life-threatening infections that must be diagnosed and treated early on.
Ensuring that people with preexisting health conditions can get and keep health insurance is the most popular part of the Affordable Care Act. It has also become a flashpoint in this fall's campaigns across the country.
Particle Metrix, developers of versatile particle characterization solutions for the life sciences, report on the work of the Baur Laboratory in the Department of Dermatology at the University Hospital of Erlangen. The Group, which is part of the Translational Research Center at the University, is working to quantify extracellular vesicles in plasma of patients.
The U.S. Food and Drug Administration today approved TOBI Podhaler (tobramycin inhalation powder) for the management of cystic fibrosis patients with Pseudomonas aeruginosa, a bacterium that causes lung infections.
› Verified 8 days ago
Entity Name | Brunswick Physician Partners Pllc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1457822264 PECOS PAC ID: 2062752470 Enrollment ID: O20190321002645 |
News Archive
nSpire Health, LLC, a leading provider of respiratory diagnostic devices and clinical trial services, issued audited results for 2010 today. Sales of $27.6M are up 3% year over year. The Company reported a $3.6M improvement in EBIT when compared to 2009 and its highest profit since the founding of the company in 2006. Cash is up $2.4M and debt reduced to less than $400K.
The persistent overuse of antibiotics has led to the evolution of antibiotic resistant pathogens, or "superbugs," which can cause severe life-threatening infections that must be diagnosed and treated early on.
Ensuring that people with preexisting health conditions can get and keep health insurance is the most popular part of the Affordable Care Act. It has also become a flashpoint in this fall's campaigns across the country.
Particle Metrix, developers of versatile particle characterization solutions for the life sciences, report on the work of the Baur Laboratory in the Department of Dermatology at the University Hospital of Erlangen. The Group, which is part of the Translational Research Center at the University, is working to quantify extracellular vesicles in plasma of patients.
The U.S. Food and Drug Administration today approved TOBI Podhaler (tobramycin inhalation powder) for the management of cystic fibrosis patients with Pseudomonas aeruginosa, a bacterium that causes lung infections.
› Verified 8 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Allen J Holmes, MD 265 Racine Dr Ste 102, Wilmington, NC 28403-8745 Ph: (910) 399-6661 | Dr Allen J Holmes, MD 265 Racine Dr Ste 102, Wilmington, NC 28403-8745 Ph: (910) 399-6661 |
News Archive
nSpire Health, LLC, a leading provider of respiratory diagnostic devices and clinical trial services, issued audited results for 2010 today. Sales of $27.6M are up 3% year over year. The Company reported a $3.6M improvement in EBIT when compared to 2009 and its highest profit since the founding of the company in 2006. Cash is up $2.4M and debt reduced to less than $400K.
The persistent overuse of antibiotics has led to the evolution of antibiotic resistant pathogens, or "superbugs," which can cause severe life-threatening infections that must be diagnosed and treated early on.
Ensuring that people with preexisting health conditions can get and keep health insurance is the most popular part of the Affordable Care Act. It has also become a flashpoint in this fall's campaigns across the country.
Particle Metrix, developers of versatile particle characterization solutions for the life sciences, report on the work of the Baur Laboratory in the Department of Dermatology at the University Hospital of Erlangen. The Group, which is part of the Translational Research Center at the University, is working to quantify extracellular vesicles in plasma of patients.
The U.S. Food and Drug Administration today approved TOBI Podhaler (tobramycin inhalation powder) for the management of cystic fibrosis patients with Pseudomonas aeruginosa, a bacterium that causes lung infections.
› Verified 8 days ago
Russell Anthony Incatasciato, D.O. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 4402 Shipyard Blvd, Wilmington, NC 28403 Phone: 910-452-1400 Fax: 910-791-9626 | |
Kevin John Reese, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 4402 Shipyard Blvd, Wilmington, NC 28403 Phone: 910-452-1400 Fax: 910-791-9626 | |
Michael Robert Ott, DO Emergency Medicine Medicare: Medicare Enrolled Practice Location: 4402 Shipyard Blvd, Wilmington, NC 28403 Phone: 910-452-1400 Fax: 910-332-1032 | |
Lisa A Plazzo, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 4402 Shipyard Blvd, Wilmington, NC 28403 Phone: 910-452-1400 Fax: 910-791-9626 | |
Dr. Robert Lee Young, DO Emergency Medicine Medicare: Medicare Enrolled Practice Location: 2131 S 17th St, Wilmington, NC 28401 Phone: 910-667-7000 | |
Dr. Sean Patrick O'brien, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 4402 Shipyard Blvd, Wilmington, NC 28403 Phone: 910-202-3363 Fax: 910-791-9626 | |
Kenneth Charles Marburg, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 4402 Shipyard Blvd, Wilmington, NC 28403 Phone: 910-452-1400 Fax: 910-332-1072 |